Literature DB >> 26909746

Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study.

Karen P H Mattos1, Gustavo R Lloret1, Maria L Cintra1, Isabela R Gouvêa2, Taís R Betoni2, Priscila G Mazzola2, Patricia Moriel2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26909746     DOI： 10.1111/pcmr.12468

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  5 in total

1.  Proteomic Response Revealed Signaling Pathways Involving in the Mechanism of Polymyxin B-Induced Melanogenesis.

Authors:  Chuhan Zhang; Xiaofen Liu; Hailan Wu; Yu Wang; Yaxin Fan; Beining Guo; Xingchen Bian; Xin Li; Jing Zhang
Journal:  Microbiol Spectr       Date:  2022-04-04

Review 2.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

Review 3.  Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review.

Authors:  Guanhao Zheng; Li Cao; Zaiqian Che; Enqiang Mao; Erzhen Chen; Juan He
Journal:  BMC Pharmacol Toxicol       Date:  2018-07-04       Impact factor: 2.483

4.  The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation.

Authors:  Dongna Zou; Haitao Yu; Feifei Li
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

5.  Low-dose intravenous plus inhaled versus intravenous polymyxin B for the treatment of extensive drug-resistant Gram-negative ventilator-associated pneumonia in the critical illnesses: a multi-center matched case-control study.

Authors:  Jiao Liu; Min Shao; Qianghong Xu; Fen Liu; Xiaojun Pan; Jianfeng Wu; Lihong Xiong; Yueming Wu; Mi Tian; Jianying Yao; Sisi Huang; Lidi Zhang; Yizhu Chen; Sheng Zhang; Zhenliang Wen; Hangxiang Du; Yongan Liu; Wenzhe Li; Yan Xu; Jean-Louis Teboul; Dechang Chen
Journal:  Ann Intensive Care       Date:  2022-08-08       Impact factor: 10.318
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.